| UniProt ID | IKBL1_HUMAN | |
|---|---|---|
| UniProt AC | Q9UBC1 | |
| Protein Name | NF-kappa-B inhibitor-like protein 1 | |
| Gene Name | NFKBIL1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 381 | |
| Subcellular Localization | Nucleus . Nuclear localization with a speckled expression pattern in some cells. Colocalizes with CACTIN in the nucleus. | |
| Protein Description | Involved in the regulation of innate immune response. Acts as negative regulator of Toll-like receptor and interferon-regulatory factor (IRF) signaling pathways. Contributes to the negative regulation of transcriptional activation of NF-kappa-B target genes in response to endogenous proinflammatory stimuli.. | |
| Protein Sequence | MSNPSPQVPEEEASTSVCRPKSSMASTSRRQRRERRFRRYLSAGRLVRAQALLQRHPGLDVDAGQPPPLHRACARHDAPALCLLLRLGADPAHQDRHGDTALHAAARQGPDAYTDFFLPLLSRCPSAMGIKNKDGETPGQILGWGPPWDSAEEEEEDDASKEREWRQKLQGELEDEWQEVMGRFEGDASHETQEPESFSAWSDRLAREHAQKCQQQQREAEGSCRPPRAEGSSQSWRQQEEEQRLFRERARAKEEELRESRARRAQEALGDREPKPTRAGPREEHPRGAGRGSLWRFGDVPWPCPGGGDPEAMAAALVARGPPLEEQGALRRYLRVQQVRWHPDRFLQRFRSQIETWELGRVMGAVTALSQALNRHAEALK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSNPSPQVP ------CCCCCCCCC | 58.40 | - | |
| 5 | Phosphorylation | ---MSNPSPQVPEEE ---CCCCCCCCCHHH | 32.01 | 25159151 | |
| 26 | Phosphorylation | RPKSSMASTSRRQRR CCCCCCCCCHHHHHH | 20.48 | - | |
| 27 | Phosphorylation | PKSSMASTSRRQRRE CCCCCCCCHHHHHHH | 19.40 | - | |
| 28 | Phosphorylation | KSSMASTSRRQRRER CCCCCCCHHHHHHHH | 23.99 | - | |
| 150 | Phosphorylation | GWGPPWDSAEEEEED CCCCCCCCHHHHHCC | 33.44 | 30175587 | |
| 160 | Phosphorylation | EEEEDDASKEREWRQ HHHCCHHHHHHHHHH | 41.88 | 29978859 | |
| 212 | Ubiquitination | LAREHAQKCQQQQRE HHHHHHHHHHHHHHH | 34.49 | - | |
| 253 | Acetylation | FRERARAKEEELRES HHHHHHHHHHHHHHH | 61.17 | 19818179 | |
| 291 | Methylation | EHPRGAGRGSLWRFG CCCCCCCCCCCCCCC | 30.87 | 54557645 | |
| 293 | Phosphorylation | PRGAGRGSLWRFGDV CCCCCCCCCCCCCCC | 24.33 | 24719451 | |
| 352 | Phosphorylation | RFLQRFRSQIETWEL HHHHHHHHHHHHHHH | 32.56 | 27251275 | |
| 367 | Phosphorylation | GRVMGAVTALSQALN HHHHHHHHHHHHHHH | 22.73 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of IKBL1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IKBL1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IKBL1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| GEMI4_HUMAN | GEMIN4 | physical | 17353931 | |
| RT22_HUMAN | MRPS22 | physical | 17353931 | |
| RFXK_HUMAN | RFXANK | physical | 17353931 | |
| LUC7L_HUMAN | LUC7L | physical | 17353931 | |
| PININ_HUMAN | PNN | physical | 17353931 | |
| RT34_HUMAN | MRPS34 | physical | 17353931 | |
| RM44_HUMAN | MRPL44 | physical | 17353931 | |
| RT18B_HUMAN | MRPS18B | physical | 17353931 | |
| K2C1B_HUMAN | KRT77 | physical | 17353931 | |
| CX056_HUMAN | CXorf56 | physical | 17353931 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 180300 | Rheumatoid arthritis (RA) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-150, AND MASSSPECTROMETRY. | |